Fibromyalgia: Causes, Diagnosis, and the Complete Treatment Guide

If you’ve been told your pain “doesn’t make sense,” that your labs are “all normal,” or, worst of all, that you’re simply anxious or depressed, you are not alone. Fibromyalgia is one of the most misunderstood conditions in modern medicine, and the gap between what science actually knows and what many patients hear in a seven-minute office visit is enormous.

Here is what the research clearly shows: fibromyalgia is a disorder of central pain processing. The nervous system has become stuck in a state of hyper-vigilance, turning up the volume on pain signals while simultaneously dampening the body’s built-in pain-dampening circuits. Brain imaging, spinal-fluid analyses, and small-fiber nerve studies have confirmed measurable, objective differences in people with fibromyalgia. This is not a diagnosis of convenience. It is a real neurological condition, and it deserves a real treatment strategy.

This guide covers everything: what causes fibromyalgia, how it’s diagnosed, what conventional medicine offers, and where integrative and regenerative therapies fit in. We grade every treatment by the strength of its evidence so you can make informed decisions with your care team.

The Three Pillars of Fibromyalgia

Fibromyalgia is far more than “body pain.” The condition is best understood as a triad, three overlapping symptom domains that feed off each other in a vicious cycle.

Understanding this triad matters because effective treatment must address all three domains, not just pain.

The Central Sensitization Mechanism: Why Everything Hurts

To understand fibromyalgia, you need to understand a concept called central sensitization. In a healthy nervous system, pain signals travel from peripheral nerves up through the spinal cord to the brain, where they are processed, modulated, and, when appropriate, dampened. Your brain has powerful descending inhibitory pathways that essentially turn the volume down on incoming pain signals. Think of it as a built-in noise-canceling system.

In fibromyalgia, that system malfunctions in multiple ways:

• Pain amplification: Dorsal horn neurons in the spinal cord become hyper-excitable. They fire more frequently and more intensely in response to the same stimulus. This is called “wind-up.”
• Lowered pain threshold: The point at which a stimulus is perceived as painful drops dramatically. Functional MRI studies confirm that fibromyalgia patients show pain-related brain activation at pressure levels that don’t register as painful in controls.
• Altered neurotransmitters: Spinal fluid studies show elevated levels of substance P (a pain-transmitting neuropeptide), sometimes 2-3× normal, alongside reduced levels of serotonin, norepinephrine, and dopamine, which are critical for descending pain inhibition.
• Glial cell activation: Emerging PET imaging research shows activated glial cells (the brain’s immune cells) in multiple brain regions in fibromyalgia patients, suggesting a neuroinflammatory component.
• Small-fiber neuropathy overlap: Up to 50% of fibromyalgia patients show reduced small-fiber nerve density on skin biopsy, suggesting a peripheral nerve component in at least a subset of patients. Learn more in our small-fiber neuropathy guide.

The practical takeaway: fibromyalgia pain is generated and maintained by the nervous system itself. The muscles and joints may feel like they are on fire, but the core problem is in the way the brain and spinal cord process signals. This is why treatments that target the nervous system, from specific medications to neurofeedback to vagus nerve stimulation, can be so effective.

Diagnosing Fibromyalgia: The 2016 ACR Criteria

There is no blood test, imaging scan, or biopsy that definitively confirms fibromyalgia. Diagnosis is clinical, meaning it’s based on a structured evaluation of your symptoms, their distribution, and their duration.

The current gold standard is the 2016 revised American College of Rheumatology (ACR) criteria, which use two validated tools:

Widespread Pain Index (WPI)

You identify how many of 19 specified body areas have been painful over the past week. Each area scores 1 point. Score range: 0-19.

Symptom Severity Scale (SSS)

You rate the severity (0-3) of three symptoms, fatigue, waking unrefreshed, and cognitive symptoms, plus the presence of additional somatic symptoms (headaches, abdominal pain, depression). Score range: 0-12.

Diagnostic Thresholds

Your doctor should also run baseline labs, CBC, CMP, TSH, ESR/CRP, vitamin D, ferritin, and ANA, not to “prove” fibromyalgia, but to identify treatable comorbidities and rule out conditions that mimic it (hypothyroidism, lupus, rheumatoid arthritis, multiple sclerosis).

Fibromyalgia vs. Lupus: How to Tell the Difference

This is one of the most commonly searched comparisons, and for good reason. Both cause widespread pain, fatigue, and cognitive problems. But they are fundamentally different conditions.

Common Comorbidities: The Conditions That Travel With Fibromyalgia

Fibromyalgia rarely travels alone. If you have fibromyalgia, there is a significantly elevated chance you also have one or more of the following conditions, and treating them can dramatically improve your overall symptom burden:

• Mast Cell Activation Syndrome (MCAS): Emerging research suggests mast cell dysfunction may drive neuroinflammation in a subset of fibromyalgia patients. Symptoms overlap significantly, pain, fatigue, brain fog, gut problems, flushing.
• POTS (Postural Orthostatic Tachycardia Syndrome): Autonomic dysfunction is common in fibromyalgia. If you get dizzy on standing, feel your heart racing, or experience exercise intolerance disproportionate to your fitness level, a tilt-table test is warranted.
• Ehlers-Danlos Syndrome (hypermobile type): Hypermobility, chronic pain, and dysautonomia frequently cluster together. The biomechanical stress of joint hypermobility may contribute to peripheral nociceptive input that maintains central sensitization.
• SIBO (Small Intestinal Bacterial Overgrowth): Studies suggest SIBO prevalence in fibromyalgia patients may be as high as 100% in some cohorts. We discuss this in detail below.
• Hypothyroidism: Both overt and subclinical hypothyroidism share multiple symptoms with fibromyalgia. Always check a full thyroid panel (TSH, free T4, free T3, thyroid antibodies), not just TSH.
• Depression and anxiety: Present in 30-50% of fibromyalgia patients. These are comorbidities, not causes. Treating mood disorders improves quality of life but does not eliminate fibromyalgia pain.
• Irritable Bowel Syndrome (IBS): Up to 70% of fibromyalgia patients meet IBS criteria. Both conditions share a central sensitization component.
• Migraine: Central sensitization also drives chronic migraine. The overlap is so strong that some researchers consider fibromyalgia and chronic migraine part of the same “central sensitivity syndrome” spectrum.

Conventional Treatments: What the Evidence Actually Says

Let’s start with the treatments that have the largest body of evidence behind them. These are not necessarily the “best” treatments, but they are the most studied, and any fibromyalgia treatment plan should at least consider them.

FDA-Approved Medications

An honest note about these medications: they help, but their effect sizes are modest. In large clinical trials, about 30-40% of patients experience meaningful (≥30%) pain reduction. They work best as one layer in a multimodal strategy, not as standalone solutions.

Exercise: The Single Strongest Treatment

ESTABLISHED, Strongest evidence of any fibromyalgia intervention

This is the part where many patients understandably push back. “How can I exercise when it hurts to walk across the room?” It is a legitimate concern, and the answer is that exercise for fibromyalgia must be approached completely differently than exercise for general fitness.

The evidence is unequivocal: aerobic exercise, strength training, and aquatic exercise all improve pain, fatigue, mood, and physical function in fibromyalgia. Meta-analyses consistently rank exercise as producing effect sizes equal to or greater than any medication. The key principles:

• Start absurdly low. Five minutes of gentle walking. Two minutes on a recumbent bike. The goal is to exercise below your symptom flare threshold.
• Progress absurdly slowly. Increase duration by no more than 10% per week. If you flare, drop back and hold steady for two weeks before trying to progress again.
• Warm water exercise is ideal for beginners. Pool temperatures of 33-35°C (91-95°F) reduce pain perception and allow movement that would be impossible on land.
• Consistency beats intensity. Three 20-minute sessions per week is dramatically better than one 60-minute session. The nervous system needs repeated, gentle exposure to movement to recalibrate.
• The first 4-6 weeks are the hardest. Initial symptom flares are common and expected. Most patients who push through this period with careful pacing report significant improvement by week 8-12.

Cognitive Behavioral Therapy (CBT) for Chronic Pain

ESTABLISHED

CBT for chronic pain is not about being told that your pain is psychological. It is a structured, skills-based therapy that helps you modify the cognitive and behavioral patterns that amplify central sensitization. Pain catastrophizing, the tendency to ruminate on pain, magnify its threat, and feel helpless about it, is a powerful predictor of pain severity and disability in fibromyalgia. CBT directly reduces catastrophizing, and meta-analyses show moderate effect sizes for pain reduction, improved function, and better mood.

Look specifically for a therapist trained in CBT for chronic pain or pain management, not general CBT. Acceptance and Commitment Therapy (ACT) is a closely related approach with emerging evidence in fibromyalgia as well.

Integrative and Regenerative Approaches

These treatments sit at the frontier of fibromyalgia care. Some have promising clinical trial data; others are based on strong mechanistic rationale and clinical observation but need larger studies. We grade each one honestly.

Low-Dose Naltrexone (LDN)

PROMISING

Low-dose naltrexone (typically 1.5-4.5 mg at bedtime) works through a completely different mechanism than full-dose naltrexone. At low doses, it transiently blocks opioid receptors, leading to a rebound upregulation of endogenous endorphins and enkephalins. More importantly, it modulates microglial activation, calming the neuroinflammatory cascade that drives central sensitization.

Multiple small randomized controlled trials (RCTs) have been published. A Stanford pilot study showed a 30% symptom reduction compared to placebo. A larger crossover study confirmed statistically significant improvements in pain, fatigue, and overall quality of life. Side effects are minimal, vivid dreams and mild headache during the first week are the most commonly reported.

LDN is not FDA-approved for fibromyalgia and must be obtained from a compounding pharmacy. But its favorable risk-benefit profile makes it one of the most exciting developments in fibromyalgia treatment.

NAD+ IV Therapy

EARLY RESEARCH

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme essential for mitochondrial energy production, DNA repair, and sirtuin activation. The hypothesis: fibromyalgia involves mitochondrial dysfunction and impaired cellular energy production, and restoring NAD+ levels via IV infusion may improve fatigue and cognitive function. Clinical data specific to fibromyalgia is very limited, mostly case series and anecdotal reports. This is a biologically plausible intervention that needs rigorous study.

Neurofeedback

PROMISING

Neurofeedback is a form of EEG biofeedback that trains the brain to modify its own electrical activity patterns. Multiple studies have shown that fibromyalgia patients have characteristic EEG abnormalities, increased theta activity, altered alpha rhythms, and disrupted sensorimotor rhythm (SMR). Neurofeedback protocols targeting these patterns have shown clinically meaningful improvements in pain, brain fog, and sleep quality in several controlled studies. A 2017 randomized trial demonstrated significant pain reduction sustained at 6-month follow-up. The treatment is non-invasive and has essentially zero side effects.

Hyperbaric Oxygen Therapy (HBOT)

PROMISING

The most compelling data comes from Israeli research groups. A landmark 2015 randomized controlled trial by Efrati et al. showed that 40 sessions of HBOT (2 ATA, 90 minutes) produced significant improvements in pain, fatigue, cognitive function, and quality of life, with SPECT imaging confirming changes in brain perfusion patterns. A follow-up study showed sustained benefits at 2 years. The proposed mechanism: HBOT reduces neuroinflammation, promotes neuroplasticity, and improves oxygen delivery to hypoperfused brain regions. The main barriers are cost and time commitment (40 sessions over 8 weeks).

Peptide Therapy

EARLY RESEARCH

Several therapeutic peptides are being explored in the context of fibromyalgia and central sensitization, including BPC-157 (for its anti-inflammatory and neurotropic properties), thymosin alpha-1 (for immune modulation), and KPV (for its anti-inflammatory effects via alpha-MSH pathways). Clinical evidence specific to fibromyalgia is almost entirely preclinical and anecdotal at this point. These agents are biologically interesting but should be considered experimental.

Vagus Nerve Stimulation (VNS)

PROMISING

The vagus nerve is the primary parasympathetic nerve, the “brake pedal” of the autonomic nervous system. Fibromyalgia is associated with sympathetic dominance and reduced vagal tone. Non-invasive transcutaneous vagus nerve stimulation (tVNS) devices have shown significant improvements in pain and fatigue in fibromyalgia pilot studies. A 2019 study using auricular tVNS showed 35% pain reduction after 2 weeks. This approach directly targets the autonomic dysfunction that perpetuates central sensitization.

Treatment Comparison: Head to Head

Diet and Fibromyalgia: What Actually Matters

Nutritional interventions won’t replace the core treatment strategies above, but they can meaningfully reduce the inflammatory and metabolic burden that contributes to central sensitization.

Anti-Inflammatory Diet

The evidence supports a whole-foods, plant-rich, minimally processed diet, essentially a Mediterranean-style pattern. Key principles:

• Emphasize omega-3-rich foods (fatty fish, walnuts, flaxseed) over omega-6-dominant seed oils
• Reduce or eliminate added sugars and ultra-processed foods, which activate inflammatory pathways
• Include polyphenol-rich foods (berries, green tea, turmeric, dark leafy greens) for their anti-inflammatory and antioxidant effects
• Consider reducing gluten and dairy for a 4-6 week trial, a subset of fibromyalgia patients report significant symptom improvement, possibly related to gut permeability

Elimination Diet

A structured elimination diet, removing the most common trigger foods (gluten, dairy, soy, corn, eggs, nightshades) for 4-6 weeks, then systematically reintroducing them, can identify individual food sensitivities. This is particularly relevant if you have significant IBS-type symptoms alongside your fibromyalgia. Work with a registered dietitian to ensure nutritional adequacy.

Vitamin D Optimization

Vitamin D deficiency is remarkably common in fibromyalgia patients, some studies report rates as high as 40-70%. Low vitamin D is associated with increased pain sensitivity, fatigue, and depression. While supplementation studies show mixed results for pain, optimizing vitamin D to a serum level of 40-60 ng/mL is a low-risk intervention that addresses a near-universal deficiency in this population. Most patients need 2,000-5,000 IU daily with vitamin K2 for proper calcium metabolism.

The Fibro-Gut Connection: SIBO and Beyond

One of the most intriguing developments in fibromyalgia research is the emerging connection between gut health and central sensitization. The gut-brain axis, the bidirectional communication highway between the gastrointestinal tract and the central nervous system, appears to be significantly disrupted in fibromyalgia.

A landmark 2004 study by Pimentel et al. found that 100% of fibromyalgia patients in their cohort tested positive for small intestinal bacterial overgrowth (SIBO) using lactulose breath testing. While that 100% figure is likely an overestimate (later studies have found rates of 30-70%), the association between SIBO and fibromyalgia is strong and has been replicated across multiple research groups.

The proposed mechanism: bacterial overgrowth in the small intestine produces excessive lipopolysaccharides (LPS) and other bacterial metabolites. These cross a compromised intestinal barrier (“leaky gut”), enter systemic circulation, and activate immune pathways that drive neuroinflammation and central sensitization. SIBO also impairs absorption of key nutrients, iron, B12, magnesium, vitamin D, that are critical for nervous system function.

Understanding Fibromyalgia Flare-Ups

A fibromyalgia flare-up is a temporary but significant worsening of symptoms, often pain, fatigue, and cognitive dysfunction all spike simultaneously. Flares can last hours to weeks, and they are one of the most frustrating aspects of living with the condition because they can erase weeks of progress.

Common flare triggers include:

• Physical overexertion: The “boom-bust” cycle, doing too much on a good day, then crashing for days afterward
• Emotional stress: Cortisol and catecholamine surges directly upregulate central sensitization
• Sleep disruption: Even one night of poor sleep can lower pain thresholds measurably
• Weather changes: Barometric pressure drops and cold/damp conditions are commonly reported triggers (the mechanism is unclear but real for many patients)
• Infections: Viral and bacterial infections trigger immune activation that can exacerbate neuroinflammation
• Hormonal fluctuations: Many women report premenstrual flares; perimenopause often worsens fibromyalgia significantly

Flare management strategies: pace activities aggressively, prioritize sleep hygiene, use gentle heat (warm baths, heating pads), practice diaphragmatic breathing to activate the parasympathetic nervous system, and avoid the temptation to “push through.” Flares are temporary, but pushing through them risks extending their duration.

What Causes Fibromyalgia? Risk Factors and Triggers

The honest answer is that we don’t know the single cause, and there probably isn’t one. Fibromyalgia appears to result from a convergence of predisposing factors, triggering events, and perpetuating mechanisms:

Predisposing factors:

• Genetic vulnerability, first-degree relatives of fibromyalgia patients have an 8× increased risk. Polymorphisms in genes related to serotonin, catecholamine, and dopamine metabolism have been identified.
• Female sex, hormonal and neuroimmune differences likely contribute
• Early-life adverse experiences, childhood trauma and chronic stress alter HPA axis function and pain processing

Common triggering events:

• Physical trauma (car accidents, surgery, injury)
• Severe emotional stress (bereavement, divorce, job loss)
• Infections (EBV, Lyme disease, hepatitis C, COVID-19)
• Autoimmune disease onset (lupus, rheumatoid arthritis)

Perpetuating factors:

• Ongoing sleep disruption
• Physical deconditioning
• Untreated comorbidities (SIBO, MCAS, hypothyroidism)
• Chronic psychological stress
• Gut dysbiosis and systemic inflammation

Frequently Asked Questions

Is fibromyalgia an autoimmune disease?

Not in the traditional sense. Fibromyalgia does not involve autoantibodies attacking specific tissues the way lupus or rheumatoid arthritis do. However, emerging research has identified autoantibodies against satellite glial cells and autonomic nerves in a subset of fibromyalgia patients, and a 2021 study showed that transferring IgG antibodies from fibromyalgia patients to mice induced fibromyalgia-like symptoms. The boundaries between “autoimmune” and “non-autoimmune” may be blurrier than we thought. For now, fibromyalgia is classified as a central sensitization syndrome, not an autoimmune disease.

Can fibromyalgia go into remission?

Yes. While fibromyalgia is considered a chronic condition, studies show that 25-50% of patients experience significant long-term improvement with appropriate multimodal treatment. True complete remission, meeting diagnostic criteria at one point and no longer meeting them years later, occurs in an estimated 10-25% of patients. The patients most likely to achieve remission are those who maintain regular exercise, achieve restorative sleep, treat comorbidities, and develop effective stress management and pacing skills.

What is the difference between fibromyalgia and chronic fatigue syndrome (ME/CFS)?

There is substantial overlap. Both involve fatigue, pain, cognitive dysfunction, and sleep disturbance. The key distinctions: ME/CFS is primarily characterized by post-exertional malaise (PEM), a disproportionate crash in response to physical or cognitive exertion, which is less prominent in fibromyalgia. Fibromyalgia is primarily characterized by widespread musculoskeletal pain, which is less prominent in ME/CFS. About 30-70% of patients with one condition also meet criteria for the other. Many researchers believe they are related conditions on a shared spectrum of central sensitization disorders.

Does fibromyalgia show up on MRI or blood tests?

Standard clinical MRI and routine blood tests are typically normal in fibromyalgia, which is actually an important diagnostic clue. However, research-grade functional MRI (fMRI) consistently shows altered pain processing in fibromyalgia brains, and PET imaging has demonstrated neuroinflammation. Experimentally, elevated substance P in cerebrospinal fluid, abnormal small-fiber nerve density on skin biopsy, and recently described IgG antibodies are all measurable biomarkers, but none are currently used as routine diagnostic tests.

Can children and teenagers get fibromyalgia?

Yes. Juvenile fibromyalgia affects an estimated 1-6% of school-age children, with higher rates in adolescent girls. The diagnostic criteria are similar to adults. The good news: children and adolescents generally have a better prognosis than adults, especially with early intervention combining exercise, CBT, and sleep optimization. Up to 80% of juveniles with fibromyalgia show significant improvement over 2-4 years.

Is fibromyalgia progressive, does it get worse over time?

Fibromyalgia is not a degenerative or progressive disease in the way that rheumatoid arthritis or multiple sclerosis can be. It does not cause joint destruction, organ damage, or reduce life expectancy. However, without treatment, symptoms can worsen due to physical deconditioning, sleep deterioration, untreated comorbidities, and chronic stress. With appropriate treatment, the trajectory is generally stable or improving.

What role do hormones play in fibromyalgia?

Hormones are a significant modulator. Fibromyalgia is 2-3× more common in women, and many patients report symptom fluctuations tied to menstrual cycles, pregnancy, and menopause. Estrogen has pain-modulating and anti-inflammatory effects, and declining estrogen levels during perimenopause frequently trigger or worsen fibromyalgia. Low cortisol (HPA axis dysregulation), suboptimal thyroid function, and low testosterone (in both sexes) are also associated with increased fibromyalgia symptom severity. in-depth hormonal evaluation is an underutilized part of the fibromyalgia workup.

Can I take LDN with my current fibromyalgia medications?

LDN can generally be combined with SNRIs (duloxetine, milnacipran), pregabalin, and most other fibromyalgia medications. The one absolute contraindication is concurrent opioid use, LDN blocks opioid receptors and will precipitate withdrawal in patients taking opioids. A washout period of 7-14 days is required before starting LDN. Tramadol, which has weak opioid activity, is also incompatible. Always discuss LDN with your prescribing physician before starting.

What is the connection between fibromyalgia and POTS?

Postural Orthostatic Tachycardia Syndrome (POTS) and fibromyalgia share autonomic nervous system dysfunction as a common mechanism. Studies have found that up to 70% of POTS patients report chronic pain, and many meet fibromyalgia criteria. The sympathetic overdrive in POTS can amplify central sensitization, while the deconditioning from fibromyalgia can worsen orthostatic intolerance. Treating POTS (salt, fluids, compression, graded exercise, medications like midodrine or ivabradine) often improves fibromyalgia symptoms as well.

Related Topics

Fibromyalgia intersects with many conditions and therapies. Explore these related guides for deeper information:

• Low-Dose Naltrexone (LDN): The Complete Guide, mechanism, dosing, and evidence for chronic pain and autoimmune conditions
• Brain Fog: Causes, Testing, and Treatment, understanding and treating the cognitive dysfunction that accompanies fibromyalgia
• Small-Fiber Neuropathy Guide, the peripheral nerve condition that overlaps with fibromyalgia in up to 50% of patients
• Neurofeedback Therapy, how EEG biofeedback retrains brain patterns associated with chronic pain
• Hyperbaric Oxygen Therapy (HBOT), the Israeli research and clinical protocols for fibromyalgia
• Mast Cell Activation Syndrome (MCAS), the inflammatory condition that frequently coexists with fibromyalgia
• SIBO: Small Intestinal Bacterial Overgrowth, the gut-brain connection and how treating SIBO can reduce pain
• POTS Treatment Guide, managing the autonomic dysfunction that amplifies fibromyalgia symptoms